TC Biopharm - TCBP Company Short-Term Debt

Graphic logo of TC Biopharm (TCBP)

The TC Biopharm (TCBP) production cycle relies on strict scheduling of sterile bio-workshops and regular equipment upgrades. TC Biopharm (TCBP) possesses significant pricing power due to its unique T-cell platform, which is indispensable for oncology patients. This chart of trading on GURU.Markets, where the metric stands at 0.00, highlights the risks of the scientific race and the probability of competitors developing more advanced treatment methods.

TCBP (TC BioPharm (Holdings) Plc) Company Short-Term Debts history from 04/28/2023 to 03/29/2025

TC BioPharm Ltd - analytical breakdowns and key metrics (TCBP)

- price and consensus price forecast:
Price Chart TC BioPharm|TCBP - Fair Value Consensus
- market capitalization data:
Market Value TC BioPharm (Holdings) Plc|TCBP - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share TC BioPharm|TCBP - Book Capitalization|Market Cap to Net Assets Ratio tcbiopharm.com|TCBP - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital TC Biopharm|TCBP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity TC Biopharm|TCBP - Company Total Debt|Debt to Book Capitalization Ratio TC BioPharm (Holdings) Plc|TCBP - Company Long-Term Liabilities|Company Current Liabilities TC BioPharm
Fundamental company valuation:TC BioPharm - TCBP
Product sample of TC Biopharm

This indicator aggregates obligations with maturities of up to one year, allowing for an assessment of current liquidity and the capital structure's sensitivity to interest rate volatility. By analyzing the dynamics of short-term debt, an investor can weigh borrowing costs against the significant pricing power of TC Biopharm (TCBP) within the inelastic demand market for cell therapy, thereby determining the business's resilience to financial risks.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|NKTR - Short-Term Debt|Company Current Liabilities Upstream Bio Corp UPB|ZBIO - Amount of Current Liabilities|IMNM (Immunome, Inc.) - Company Short-Term Debts|Company Current Liabilities gossamerbio.com|KALV - Company Current Liabilities|Company Short-Term Loans and Borrowings Septerna, Inc.|Company Short-Term Debts Pieris Pharmaceuticals Inc (PVLA)|Company Short-Term Debt Savara Pharma (SVRA)|Company Short-Term Debts RIGL|anaptysbio.com - Short-Term Debt Volume|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debt|ENGN: Short-Term Debt|Company Short-Term Debt RAPT Therapeutics (RAPT)|Aerovate Therapeutics (JBIO) - Current Liabilities|ACRS - Company Short-Term Debts|Company Short-Term Loans and Borrowings kyvernatx.com|Company Short-Term Debts TLSA|Company Short-Term Debts CABA (Cabaletta Bio Inc.)|Company Short-Term Debt Ventyx Bio|Theratechnologies, Inc - Company Short-Term Loans and Borrowings|AVTX: Company Short-Term Debt|eledon.com (ELDN) - Company Current Liabilities|AGEN - Company Current Liabilities|Climb Bio Inc. (CLYM) - Amount of Current Liabilities|Company Short-Term Debts ZURA|Company Current Liabilities aTyr Pharmaceuticals|Company Short-Term Debts Adagene (ADAG)|Company Short-Term Debt IMA (ikenaoncology.com)|Shattuck Labs (STTK) - Company Short-Term Debt|Equillium Inc - Current Liabilities|Company Short-Term Debt Connect Pharma|IMUX - Current Liabilities|Company Short-Term Debts atarabio.com ATRA|InflaRx (IFRX) - Company Short-Term Loans and Borrowings|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts ACET|Celularity Inc. (CELU) - Company Short-Term Debt|Company Short-Term Loans and Borrowings INMB (INmune Bio Corporation)|Barinthus Biotherapeutics - Company Short-Term Debt|Company Current Liabilities kezarlifesciences.com KZR|SAB Biotherapeutics, Inc. - Company Short-Term Debts|Akari Therapeutics PLC (AKTX) - Company Short-Term Debts|Company Current Liabilities enlivex.com ENLV|Q32 Bio (QTTB) - Company Short-Term Loans and Borrowings|GOVX: Company Short-Term Debts|Short-Term Debt Volume EDSA|Company Short-Term Debt IBIO (iBio)|Company Current Liabilities CARM (carismatx.com)|XTL Biopharmaceuticals, Ltd. - Company Short-Term Debt|BOLT - Company Current Liabilities|HCW Biologics Inc - Company Current Liabilities|APVO: Company Short-Term Debts|Company Short-Term Debt AIM ImmunoTech Inc.|Aditxt, Inc. (ADTX) - Company Short-Term Indebtedness|Company Short-Term Debts GRI (GRI Bio Corp)|Short-Term Debt XORTX Corp (XRTX)|Company Current Liabilities Vyome Holdings Inc|Amount of Current Liabilities revbiosciences.com (REVB)|Indaptus Therapeutics, Inc. - Company Short-Term Debts|SCNI - Company Current Liabilities|Company Current Liabilities CalciMedica Corp (CALI)|AFMD - Company Short-Term Loans and Borrowings|allakos.com (ALLK) - Company Short-Term Debts|HOOKIPA Pharma (HOOK) - Company Short-Term Debt|IGMS: Company Short-Term Debts|Short-Term Debt Volume ITOS|Ocean Bio - Company Short-Term Debt|Short-Term Debt THRD (Third Harmonic Bio Inc)